Mamento, Guiahida S.
HRN: 21-28-25 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/24/2022
CEFUROXIME 1.5GM (VIAL)
04/24/2022
05/01/2022
IVT
1.5
Q8
CAP; Infectious Diarrhea
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes